Background: The conversion of atrial fibrillation (AF) to sinus rhythm is associated with transient dysfunction of the left atrium (LA). This study aimed to investigate the time course of LA function and inflammation after radiofrequency (RF) ablation for paroxysmal AF. Methods: Fifty-three patients with paroxysmal AF undergoing RF ablation were recruited. White blood cells were counted and high-sensitivity C-reactive protein (hs-CRP), fibrinogen, and D-dimer levels were measured. LA emptying fraction, strain, and strain rate were evaluated before RF ablation and at 1, 2, 3, and 4 weeks and 2 and 3 months after ablation using conventional Doppler echocardiography and two-dimensional speckle-tracking echocardiography. Results: LA emptying fraction sharply decreased at day 7 after ablation and then slowly increased ( p < 0.05) and returned to the baseline value at day 28. LA strain and strain rate values sharply decreased at day 7 after the procedure and then slowly increased ( p < 0.05). A significant correlation between hs-CRP level and LA emptying fraction was found at day 7. Conclusion: Reduced LA function and increased prothrombotic tendency were found at~1 week after AF ablation for paroxysmal AF. Therefore, monitoring the time and degree of anticoagulation after ablation for paroxysmal AF might effectively prevent thromboembolic events and reduce anticoagulant cost and bleeding risk.
Introduction
Atrial fibrillation (AF) is a growing global health concern associated with an increased morbidity and mortality due to stroke and heart failure (HF), thus impairing quality of life. Radiofrequency (RF) ablation for AF, an important therapeutic modality for patients with AF, is known to cause an increase in several inflammation markers. 1, 2 Inflammation is increasingly recognized to play a significant role in the genesis and perpetuation of AF. 3, 4 It is generally accepted that cardioversion of AF to sinus rhythm is associated with a reduction in left atrium (LA) and LA appendage blood flow velocity. 5, 6 Patients with AF undergoing ablation are at increased risk of thromboembolic events, as well as atrial stunning, particularly in the first 2 weeks after the procedure, although the exact mechanisms are not known. 7 Results regarding the occurrence and duration of atrial stunning and the amount of anticoagulants after RF ablation for AF to effectively prevent thromboembolic events have differed. 3 At present, it is not known whether
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The purpose of this study was to investigate the specific time course of LA function, inflammation, and prothrombotic response after RF ablation for paroxysmal AF using twodimensional speckle-tracking echocardiography (2D-STE), which is a noneDoppler-based technique, 8 to help provide guidance in anticoagulation treatment decisions after RF ablation for AF.
Methods

Patients
Sixty consecutive patients aged less than 80 years experiencing paroxysmal AF who underwent circumferential pulmonary vein isolation (CPVI) were enrolled. Exclusion criteria were acute or chronic infection, left ventricular (LV) dysfunction, LA diameter >50 mm, atrial thrombosis, valvular heart disease, hyperthyroidism, previous prosthetic heart valve replacement, history of AF ablation, existing liver or kidney disease, malignant tumors, and any hematological system disease. The AF type was defined according to the Heart Rhythm Society expert consensus statement. 9 
Ablation procedure
Before the procedure, all patients underwent anticoagulation treatment with warfarin for 6 or more weeks to maintain their international normalized ratio between 2 and 3. Warfarin administration was stopped 7 days before the procedure and replaced with enoxaparin at a dose of 1 mg/kg twice a day, which was stopped at least 12 h before the operation. Transesophageal echocardiography was performed to exclude LA thrombus. All antiarrhythmic agents were ceased for 5 half-lives before the procedure.
All patients underwent CPVI performed using the same procedure, and no additional ablation was performed at the extrapulmonary sites unless atrial flutter was diagnosed before operation. All patients underwent pulmonary vein-LA reconstruction under computed tomography before the operation for a better illustration of the LA and pulmonary vein structures. The ablation catheter, after passing through the transseptal sheath, was inserted under pressure into the LA to perform RF ablation, and the procedure was monitored using a threedimensional electro-anatomical mapping system (Carto 3; Biosense Webster). The mapping catheter for the circumferential pulmonary vein was used to record pulmonary vein potentials before, during, and after circumferential pulmonary vein ablation (Lasso ® NAV Eco; Biosense Webster). The default strategy was to create a circle surrounding the two ipsilateral pulmonary veins. The operative endpoint was the entrance and exit block of the pulmonary vein potentials. Monitoring was carried out for 20e30 min after the entrance and exit block of the pulmonary vein potentials. Pulmonary vein potential conduction was detected again and, in case of recovery, ablation was carried out continuously.
Blood collection
Peripheral blood samples were collected for a total white cell count (WCC) and measurement of high-sensitivity C-reactive protein (hs-CRP), fibrinogen, and D-dimer levels before the operation and at 1, 2, and 3 days; 1, 2, 3, and 4 weeks; and 2 and 3 months after the operation. Samples were analyzed immediately.
The total WCC was evaluated using Sysmex XN2000 (Sysmex, Kobe, Japan). The hs-CRP was analyzed using an immunoturbidimetric latex CRP assay (LABOS PECT 008AS; Hitachi, Osaka, Japan). Fibrinogen and D-dimer were evaluated using the STAR coagulation analyzer (ACLTOP700; Beckman Coulter, Chaska, MN, USA). Normal reference ranges were the following: WCC, 3.5e9.5 ( Â 10 9 /L); hs-CRP, lower limit of detection 0.08 mg/L; fibrinogen, 2.38e4.98 g/L; and D-dimer, 0e0.232 mg/L.
Echocardiographic assessment
Echocardiography was performed preoperatively, at 1, 2, 3, and 4 weeks and 2 and 3 months postoperatively using a commercially available echocardiographic system (iE33 machines equipped with X3; Philips Medical Systems, Eindhoven, Netherlands). All parameters were analyzed by one experienced echocardiographer using QLAB software (version 9.0; Philips Medical Systems). The LV ejection fraction was assessed using the biplane Simpson disk method. 10 In the parasternal long-axis views, the LA maximum anteroposterior diameter was measured. In the apical four-chamber view, the LA maximum volume at the end of LV systole, just before the opening of the mitral valve, and the LA minimum volume at the end of LV diastole, just after the closure of the mitral valve, were measured. 11 The LA emptying fraction was calculated as follows ([LA maximum volume -LA minimum volume]/LA maximum volume) Â 100. The LA maximum volume was also measured using the biplane area-length method. 12 Early (E) and late (A) diastolic filling velocities were measured using pulsed-wave Doppler at the mitral valve leaflet tips. For tissue Doppler imaging (TDI), the peak early diastolic tissue velocity (E 0 ) was recorded from a fourchamber view at the lateral and septal border of the mitral annulus. The septal and lateral measures were averaged according to previous reports. 13 
Speckle tracking
Longitudinal LA strain was evaluated using speckletracking echocardiography (two-dimensional cardiac performance analysis; QLAB software; Philips Medical Systems).
The data from 12 LA segments (mid, annular, and superior segments along the lateral, septal, inferior, and anterior LA walls using apical four-chamber and two-chamber images) were averaged to determine the global LA peak systolic strain (εP) during LV ejection (LA reservoir phase). The peak strain rate (SR P ) was measured during LV ejection (LA reservoir phase). The peak early diastolic strain rate (SR E ) was measured during LV early diastole (LA conduit phase), and peak late diastolic strain rate (SR A ) was measured during LV diastole occurring after the P wave (active contraction phase).
Follow-up
Continuous monitoring was performed for 3 days after ablation. Outpatient follow-up visits were scheduled at 1, 2, 3, and 4 weeks and 2, 3, and 6 months after the procedure. Patients were monitored using an electrocardiogram (ECG), and 48-h ambulatory electrocardiogram recordings (Holter) were performed twice a month to determine the presence of recurrent arrhythmias at each visit starting at 1 month after the ablation. Recurrent arrhythmia was defined as any atrial arrhythmia !30 s. 9 Early recurrences were defined as any atrial arrhythmia !30 s within the first 3 months after the procedure documented using the Holter monitor or any 12-lead ECG.
Anticoagulation treatment was administered for at least 3 months. Administration of anticoagulants was stopped at this point in the absence of recurrent arrhythmia in patients with a CHADS2 score 1 (the CHADS2 score includes congestive heart failure, hypertension, age >75 years, diabetes, and previous stroke/transient ischemic attack; the score is a clinical prediction rule for estimating the risk of stroke in patients with non-rheumatic AF). Otherwise, anticoagulation treatment was administered for 12 months, and its suspension was discussed on an individual basis.
Statistical analyses
Parametric values are expressed as mean ± standard deviation, and categorical data are expressed as counts and percentages. Comparisons between continuous variables, such as biomarker values, were performed using Student's t-test. Categorical variables were compared using Fisher's exact test or the c 2 test as appropriate. Linear mixed-effects models were created to examine the temporal changes in biochemical markers and echocardiographic variables after RF ablation, in which time was included as a fixed effect and a compound symmetry correlation structure allowed for correlation within patients because of repeated measurements. If the time main effect was significant, post hoc testing was used to reveal where the significant differences lay. Spearman's rho was calculated to examine bivariate correlation. A p value < 0.05 was considered statistically significant. The Statistical Package for Social Sciences (SPSS) for Windows, version 13.0 (SPSS, Chicago, IL, USA), was used for statistical analyses.
Results
Baseline characteristics
Patient demographics and procedural characteristics are shown in Table 1 . The mean CHADS2 score was 0.86 ± 0.42. The RF ablation time for pulmonary vein isolation was 120.8 ± 24.6 min. Among the 60 patients initially screened, three patients met the exclusion criteria (Fig. 1) . At least 53 patients were examined, four of whom failed to appear for more than one visit or Holter recording and were excluded from this study.
Inflammation time course and prothrombotic markers
All markers showed a significant time-dependent increase after RF ablation for paroxysmal AF compared with the baseline values ( p < 0.05 for all markers). The total WCC significantly increased from day 1 to day 7 after the procedure (Fig. 2A ). The hs-CRP level significantly increased from day 1 to day 14 after RF ablation, after which a slow decline occurred; the peak increase occurred from day 2 to day 3 ( Fig. 2B) . Prothrombotic markers reached the highest value at approximately 3 days and 1 week after RF ablation for paroxysmal AF. Fibrinogen levels were significantly increased from day 2 to day 3 and at 1 week after the procedure (Fig. 2C) . D-dimer levels significantly increased from day 1 to day 28, with the highest peak at 1 week after the procedure (Fig. 2D ).
LA function and strain analysis
LA diameter, maximum LA volume, and peak E-wave velocity after RF ablation for paroxysmal AF were not significantly different from the baseline values (Fig. 3AeC) . In contrast, A-wave velocity showed a sharp decrease compared with the baseline value at day 7 after RF ablation and then slowly increased (Fig. 3D) .
Regarding TDI, no difference was detected in the peak early diastolic tissue velocity (E 0 ) after RF ablation (Fig. 3F) . During the follow-up period, the index did not show any significant modification.
LA emptying fraction sharply decreased at day 7 after RF ablation for paroxysmal AF (from 55.9% ± 10.1e45.8% ± 7.4, p ¼ 0.001) and then slowly increased, returning to baseline values at day 28 (Fig. 3E) . However, a small increase was observed at day 60 (60.9% ± 12.5%, p ¼ 0.006) and at day 90 (60.8% ± 13.3%, p ¼ 0.006).
In the overall study population, LA strain and strain rate sharply decreased at day 7 after the procedure and then showed a slow increase. The global εP was significantly lower at day 7 after the procedure and significantly increased at days 60 and 90 (Fig. 4A) . In addition, SR P and SR A clearly decreased at day 7 after the procedure, and SR P decreased while SR A increased at day 90 after RF ablation (Fig. 4B and  D) . Finally, SR E sharply decreased at day 7 after the procedure and increased at days 60 ( p ¼ 0.035) and 90 ( p ¼ 0.011) compared with the baseline (Fig. 4C) .
Correlation between LA function and inflammation
A significant correlation between hs-CRP level and LA emptying fraction was found at day 7 (r ¼ À0.45, p ¼ 0.03).
Follow-up and AF recurrence
AF early recurrence was observed in 11 (20.8%) of 53 patients after 3 months. AF recurrence was observed in 14 (26.4%) of 53 patients after 6 months.
Complications such as vagus reflex and fluid overload were reported during catheter ablation. However, all patients recovered after an effective medical treatment, and no one withdrew from the study. Two patients had mild fluid overload requiring diuretic therapy. Two patients developed sinus bradycardia and underwent pacing.
Discussion
AF is associated with progressive atrial mechanical remodeling. Reverse remodeling and recovery of atrial function after RF ablation are both important targets of any AF treatment.
14 Atrial thrombi may occur as a consequence of reduced LA function despite the restoration of sinus rhythm and RF ablation. 5 In addition, inflammation, as a consequence of ablation, may alter the mechanical properties and the electrical activities of the atrium.
15e17 This study showed the specific time course of LA recovery and inflammation after ablation.
Currently, there is no standard method for the measurement of LA function. Transmitral flow velocity with pulsed Doppler imaging will show the flow velocity resulting from atrial contraction. However, it is highly dependent on loading conditions and diastolic function. We used 2D-STE (a novel noneDoppler-based method) to evaluate LA function. 18 LA strain and strain rate imaging using tracking of acoustic kernels by 2D-STE, 19 a novel angle-independent tool for measuring myocardial stretch with the ability to quantitatively analyze global and regional LA contractility and relaxation, could therefore serve as a noninvasive tool to identify contractile dysfunction, overcoming the existing limitations of Doppler-based technologies. 20, 21 Our results showed that the LA emptying fraction and the A-wave velocity sharply decreased from baseline at day 7 after RF ablation for paroxysmal AF and then slowly increased. The postoperative significant increase in the LA emptying fraction demonstrated improvement in atrial compliance (reservoir function). Since most of the atrial stunning resolves in 48e72 h after cardioversion and the time course of LA function recovery is not clearly defined, 5, 22, 23 our results may suggest that at 7 days after RF ablation, the strain rate in each segment of the atrial wall was significantly lower than that before the operation, suggesting that the LA function was in a deteriorating phase. At 3 months after RF ablation, LA remodeling and function in patients with paroxysmal AF were partly improved, LA blood storage function was decreased, and auxiliary pump function and pipeline function were increased. 24 However, the real mechanism of LA remodeling after ablation has not been clearly elucidated. Oral et al. 7 found that patients with AF undergoing ablation were at increased risk of thromboembolic events, particularly in the first 2 weeks after procedure. Our results demonstrated that patients with paroxysmal AF showed significant impairment in LA compliance (reservoir function) at day 7 after the procedure. This might explain the increased risk of early thromboembolic events after ablation. During the postoperative period, εP was significantly increased at 2 months, suggesting that this postoperative improvement in atrial compliance might be because LA function was still reversible. We also observed a significant improvement in the LA conduit function during the follow up, as demonstrated by SR E .
The hs-CRP and D-dimer levels are positively correlated with stroke and thromboembolic events in AF. 25, 26 In our study, patients undergoing ablation exhibited an inflammatory response within the first 3 days during the postoperative period, with high expression of prothrombotic markers at 1 week after ablation for paroxysmal AF. This also might explain the increased risk of early thromboembolic events after ablation. These findings suggested that inflammation could be an important factor contributing to the increased prothrombotic state in paroxysmal AF soon after ablation. In addition, in our study, we found a significant correlation between hs-CRP level and LA emptying fraction. Our finding was in agreement with the reports of Mattioli et al. 27 and Dernellis et al. 28 who revealed that hs-CRP and serum iron levels could predict LA function. Further studies are needed to investigate this mechanism.
A limitation of this study is the small number of patients enrolled as we included only patients with normal LV ejection fraction and no valvular disease. In addition, we included patients with only paroxysmal AF. In cases of persistent AF, it is very difficult to have periods of sinus rhythm long enough to allow good-quality images for echocardiographic assessments or a sufficient number of patients.
In conclusion, reduced LA function and increased prothrombotic tendency were found approximately 1 week after RF ablation in patients with paroxysmal AF. Strategic antithrombotic measures targeting this specific time frame might further indicate the time and degree of anticoagulation, as well as effectively prevent thromboembolic events and reduce anticoagulant cost and bleeding risk.
